Publication Name	World Journal of Gastroenterology
Manuscript ID	3017
Country	Japan

Received	2013-04-02 20:19
Peer-Review Started	2013-04-03 14:11
To Make the First Decision	2013-05-02 09:03
Return for Revision	2013-05-17 18:24
Revised
Second Decision	2013-06-18 14:55
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-06-19 01:04
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-07-19 22:55
Typeset the Manuscript	2013-08-01 15:19
Publish the Manuscript Online	2013-08-19 18:22

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Case Report
Article Title	Complete response to multidisciplinary therapy in a patient with primary gastric choriocarcinoma
Manuscript Source	Invited Manuscript
All Author List	Kazuhiro Takahashi, Shigeki Tsukamoto, Ken Saito, Nobuhiro Ohkohchi and Katsu Hirayama
Funding Agency and Grant Number
Corresponding Author	Shigeki Tsukamoto, MD, PhD, Department of Surgery, Hiraka General Hospital, 3-1 Yatsukuchi, Maegou, Yokote 0138610, Japan. fc13btkai@ybb.ne.jp
Key Words	Primary gastric choriocarcinoma; Beta-human chorionic gonadotropin; Etoposide; methotrexate; actinomycin D; cyclophosphamide; and vincristine; Oligometastatic; Radiofrequency ablation
Core Tip	multidisciplinary treatment including surgery, chemotherapy, and radiofrequency ablation (RFA). The patient has been alive with no evidence of disease for 10 years. To the best of our knowledge, this patient with recurrent primary gastric choriocarcinoma has achieved the longest survival. The present case is the first report of choriocarcinoma metastatic to the lung successfully treated with RFA. From our retrospective analysis of recurrent or unresectable primary gastric choriocarcinoma, we propose that gonadal choriocarcinoma regimens can be considered as first-line for primary gastric choriocarcinoma.
Publish Date	2013-08-19 18:22
Citation	Takahashi K, Tsukamoto S, Saito K, Ohkohchi N, Hirayama K. Complete response to multidisciplinary therapy in a patient with primary gastric choriocarcinoma. World J Gastroenterol 2013; 19(31): 5187-5194
URL	http://www.wjgnet.com/1007-9327/full/v19/i31/5187.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i31.5187

Full Article (PDF)	WJG-19-5187.pdf
Manuscript File	3017-Review.docx
Answering Reviewers	3017-Answering reviewers.pdf
Copyright License Agreement	3017-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	3017-Language certificate.pdf
Peer-review Report	3017-Peer review(s).pdf
Scientific Editor Work List	3017-Scientific editor work list.doc